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Mter  exposure to streptomycin a  number of different organisms have been 
shown to decrease  in  their  sensitivity  to this  antibiotic  (1-5).  This change, 
which can be  demonstrated  with  regularity  in  vitro,  has  been  considered  to 
be responsible for therapeutic failure in a significant number of patients (6-11). 
Investigation  of this  phenomenon  in  H.  influemae  infections  has  suggested 
that when streptomycin  is used  as the only therapeutic  agent,  emergence of 
resistance is conditioned by the severity of infection and therefore presumably 
by the size of the bacterial population in the patient (8).  Of fourteen patients 
treated  with  streptomycin  alone  ten  recovered without  amplification  of the 
therapeutic program; but in three of the four remaining cases failure was proved 
to bedue to a change in the sensitivity of the organisms.  Growth of the strains 
cultivated  from "these  patients  before  treatment  was  completely  prevented 
by a  concentration  of streptomycin  varying between  1  and  7  units  per cc., 
whereas strains cultivated from the same patients  after a  period of treatment 
grew luxuriantly in concentrations of streptomycin as high as 1000 units per cc. 
Detailed investigations on the organisms grown from one of these patients, 
No. 1, during treatment provided evidence of importance in our understanding 
of the development of strain resistance. 
A 2 year old boy had been well and running about only 24 hours before admission to hospi- 
tal.  He had received no specific treatment.  When  first  examined he was  semicomatose 
and presented signs of meningeal irritation  but no evidence of localized cerebral involvement. 
Examination  of the  spinal  fluid confirmed the  clinical impression  that  the infection  had 
progressed to a severe degree within a 24 hour period.  The spinal fluid showed numerous 
type b H. influ~nzae on stained smear and the sugar concentration was 5 mg. per cent.  The 
patient appeared  to offer an ideal case of severe meningitis on which to test the influence of 
streptomycin  because he had received no other therapy and because  treatment could be 
applied early in the course of the disease.  Streptomycin was used according to the standard 
method  already  described  (8 b).  Within  24 hours  he  became  oriented,  his  temperature 
was lower, and the neurologic signs had stopped progressing.  This state continued for the 
next 2 days.  The spinal fluid showed marked improvement within 24 hours; no organisms 
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were seen on microscopic examination of stained smears of sediment, and the concentration 
of sugar was normal.  On the 3rd day, however, the culture of the spinal fluid withdrawn 
24 hours after institution  of streptomycin therapy showed growth of H. influenzae which 
thrived in 1000 units of streptomycin per cc.  In spite of the intrathecal use of streptomycin 
twice daily ~or the next 2 days, rapid growth of H. influenzae occurred from all samples of 
spinal fluid and  the  sugar concentration decreased.  Clinically the  child became rapidly 
worse; convulsions of the entire right side appeared and continued Intermittently for several 
days.  Signs of hemiparesls became obvious.  Streptomycin was discontinued on the  4th 
day of treatment  and type-specific rabbit  antiserum and suifadiazine were administered. 
Rapid improvement followed; s!gns of infection cleared by the 3rd day and by the end of the 
4th week the patient  used all extremttles normally.  All cultures of tt. influenzae isolated 
from this child's cerebrospinal fluid after the start of streptomycin treatment were resistant 
to 1000 units per cc.; this was true of i00 per cent of the bacterial population, not only when 
first isolated but also after subculturing for 3 months in the absence of streptomycin.  More- 
over, the H. influenzae strain  isolated from the nasopharynx after the start of treatment 
¢xklbited a similar degree of resistance.  Nasopharyngeal cultures, 1 year after the child's 
tecov~y, continue to show type b H. influemae resistant to 1000 units of streptomycin per cc. 
The susceptibility of pathogenic organisms to critical concentrations of strep- 
tomycin in  their  fluid  environment  obviously lies  at  the  root  of successful 
therapy with this antibiotic; and the development of strain resistance in some 
patients  during  treatment  constitutes  a  phenomenon  of prime  importance. 
Study  of resistance of a  number of organisms to  other  antibacterial agents 
has led  to  two  schools of thought.  One maintains  that  the  metabolism of 
the bacteria is changed as a result of exposure to the agent and the other that 
resistant members are present in  the bacterial population from the  start of 
the infection. 
According  to  the  latter  theory,  which  is well  supported  by experimental 
data from a  number of investigators (12-17) and which conforms also to our 
own results,  the emergence of resistance represents a  selective process.  The 
usual in vitro sensitivity tests, involving relatively small numbers of organisms 
and thus failing at times to include samples of the comparatively rare resistant 
members of the initial bacterial population,  reflect a  conventional degree of 
sensitivity of the strain under investigation to the antibiotic used.  However, 
ha the course of treatment of the patient,  the more sensitive members of the 
bacterial population  are killed off and subsequent  tests of sensitivity reflect 
survival of resistant forms.  Selective survival alone explains the rapid changes 
in susceptibility often found.  For example, in the patient  (No.  1)  described 
in detail,  resistance of the  strain  to  more than  1000  units  of streptomycin 
per co. was found within 24 hours of exposure to streptomycin; in fact, careful 
colony counts showed that  100  per cent of the bacterial population  resisted 
this concentration,  and that  all  sensitive organisms had  been  killed.  It  is 
hard to believe that so short a period would permit a fundamental change to 
occur in the  metabolism  of  the  surviving  organisms  as  to  enable  them  to 
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streptomycin has a  rapid bactericidal action which promptly kills enormous 
numbers of sensitive organisms (18).  The latter comprise virtually the entire 
population, but there is present initially a minute number of organisms which 
differ from the rest of the population in that they can thrive in a high con- 
centration of streptomycin, in the example cited, over 1000 units per cc. 
This  hypothesis was  examined  by  experimental  methods  which  studied 
three aspects of the problem: influence of the size of the bacterial population 
on  the  minimal effective concentration  of  streptomycin,  examination  of a 
number  of  different strains,  before  any exposure  to  streptomycin,  for  the 
presence of organisms resistant to 1000 units per cc., and comparison of strains 
from patients in whom streptomycin failed with those isolated from the group 
successfully treated. 
Two  in  ~tro  procedures  were  used  for  these  purposes.  One  tested  the 
influence of concentration of streptomycin ranging from 1 to 13 units per cc. 
on a relatively small inoculum (varying from 1 million to 1700 million organ- 
isms);  1 the  other  examined  large  bacterial  populations,  142  billion  to  522 
billion organisms, of ten of these strains for presence of members which are 
resistant to 1000 units of streptomycin per cc. 
Comparison  of Strains by in Vitro Sensitivity Tests Using Inoculum of I Million 
to 1700 Million Organisms 
Strains of H.  influemae cultivated before and after start of treatment in 
all  patients were  tested  for sensitivity to  streptomycin by  the  s~me  test. 
The method (5) determines the minimal concentration of streptomycin which 
when incorporated in Levinthal agar completely  prevents growth of an inoculum 
varying from 1 million to 1700 million organisms after an incubation period 
of 48 hours; this value is termed theminimal effective concentration or ~.~.c. 
The results obtained on the strains isolated before treatment are listed in Table I. 
Patients 1, 2, and 3 represent streptomycin failures; the corresponding strains 
developed resistance to streptomycin during the course of treatment.  Strains 
5 to 13 were cultivated from patients in whom streptomycin therapy was suc- 
cessful.  The spinal fluid of patient 4 cleared rapidly but death occurred on 
the  5th  day;  an  enormous  subarachnoid  abscess  was  found  postmortem. 
It is seen that the x*.~.c, of strains varied from test to test and also depended 
upon whether the source of inoculum was a 6 hour Levinthal broth culture or 
a 6 hour growth on Levinthal agar, a 2 ram. loop being used in each instance; 
the  size  of  the  bacterial  population  transferred from agar plates  averaged 
approximately 700 times that from broth tubes.  The mean M.~..c. and standard 
deviations have been computed for two purposes: to determine whether  the 
larger inoculum, from Levinthal agar source,  averaging  700,000,000  organ- 
isms,  requires  significantly higher  concentrations  of  streptomycin  to corn- 
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pletely  prevent  growth  under  conditions  of  experiment,  and  whether  the 
K.v..c.  of  strains cultivated from patients in whom  streptomycin  treatment 
failed, differs significantly from the ~.E.c.  of strains from patients  in  whom 
TABLE I 
In Vitro Sensiti~y Teas on Levlnthal Agar Containing Concentrations of Streptomycin Varying 
from 0.5 to 13 Unils per Cc. 
Size of inoculum 1 million to 1700 million 
Patient  and strain 
1'  1  ~.  =,  2.0  2 
~.D. =  1.18  3 
~i.  -  1.87 
-  o.74' 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Source of inoculum 
L~in~albm~* 
No. of tests 
 lmlmll 
M.z.c. units per ~. 
1,1  1.1  1.~ 
0,8  1.1  2.8  3.5 
2.0  5.0  3A]  3.0 
0.8  1.1  1.~  2.6 
1.6  2.8 
1.6  1.6 
0.8  2.8 
1.6  2.8 
2.8 
1.2  ! 
0.8 
1.6  I 
1.6 
1.1  2.5  2.8 
M.  ~,  1.97 
S.D.  =  0.97 
Levinthai  agar$ 
No. of tests 
1  2  3  4 
x.z.c,  units per ~. 
4.4  2.8  4.4 
2.5  2.7  7.54.4 
3.0  5.0  5.03.0 
1.6  2.6  4.4 
7.5  lO.7111 
4.4  4.4 
1.6  7.5 
7.5  13.011 
7.5  ~  7.5 
7.5 
2.7 
3.6  i 
7.711! 
2.5  2.7  10.8 i 
M. ,,- 5.31 
S.D. =- 2.86 
Clinical  results 
F' Y  1  -3S 
"  I  S.D. =  1.45 
Recovered' 
¢c 
¢c 
c~ 
~¢  M°  ml 
"  S.D.  ,,, 
IG 
c¢ 
6.41 
3.1~ 
M.E.C, minimal effective concentration. 
M.  m mean. 
S.D. =  standard deviation. 
* 2 ram. loop inoculum averaged 1,000,000 organisms. 
:~ 2 ram. loop inoculum averaged 700,000,000 organisms. 
§ Numbers indicate number of tests carried out. 
]] 1 to 2 colonies grew in this dilution--higher  concentration not used. 
this therapy was successful.  It-is seen that there is no significant difference 
between  the  sensitivity of  organisms isolated from  the  unsuccessful  group 
and those cultivated from the successful group.  Moreover the  difference in 
inoculum size between broth and agar source is not great enough to  influence 
the M.E.C. significantly.  There occurred occasionally  on the plates of Levinthal 
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of resistant colonies, small in number and usually less than 5, which varied 
in incidence in repeated tests on the same strain, suggesting a  chance phe- 
nomenon.  Nonetheless it can be seen that the M.~.c. of all strains falls within 
the range of 1 unit per cc. to 13 units per cc. with the one exception noted. 
The values for the first three strains, which emerged resistant during strep- 
tomycin treatment,  are  not  significantly different from those  of the  other 
strains  listed.  These  in  vitro  results  correlated  well  with  those  obtained 
in trivo.  Mouse protection  tests  showed  a  striking  difference between  the 
sensitivity of the strains before and after emergence of resistance as judged 
by in vitro tests (5, 8).  The original cultures, which in vitro showed an M.v..c. 
of 1 to 13 units per co., had an ~.~.D.  (the minimal effective dose of strep- 
tomycin which protected 50 per cent of mice against 1,000,000 M.L.D.) between 
19 and 78 units per mouse.  After treatment with streptomycin the strains 
which thrived in the presence of 1000 units per cc. in vitro were so resistant in 
mice that 5000 units per mouse failed to protect. 
Mter  exposure  to  streptomycin during  treatment,  strains  from patients 
1, 2, and 3 exhibited resistance to 1000 units of streptomycin per cc.  No. 1 
emerged resistant within 24 hours after the start of treatment.  No. 2, first 
retested  after  21  days  of  therapy,  and  No.  3,  when  first  retested  on 
the  3rd  day,  both  resisted  1000  units  of  streptomycin  per  cc.  at  these 
times.  In all other  patients  spinal  fluid  cultures  were  sterile  within  48 
hours.  The strains from four of these successfully treated patients, isolated 
24 hours after'beginning streptomycin, all showed an M.v..C. within the range 
of 1 and 7 units per cc.  Likewise the organisms isolated from the nasopharynx 
of several patients during and following successful treatment exhibited com- 
parable sensitivity.  Therefore the routine in vitro test, which failed to differ- 
entiate in advance those strains which developed resistance during treatment, 
provided a  satisfactory index of efficacy of streptomycin in  a  given patient 
when applied to strains cultivated after exposure to the antibiotic. 
Comparison  of Large Bacterial Populations (142 to 522 Billion) for Incidence 
of Organisms,  in  the  Original  Cultures,  Which  Resist 
1000  Units  of Streptomycin  per  Cc. 
In  this phase  of the work large samples of the  original strains, prior  to 
therapeutic use of streptomycin, were searched for the possible inclusion among 
them  of  resistant  forms.  Certain  factors  simplified  the  problem.  When 
emergence of resistance was responsible for therapeutic failure  ~  the organisms 
grew in or on Levinthal agar containing 1000 units per co. of streptomycin. 
This concentration was so rapidly bactericidal for sensitive organisms that it 
was possible to inoculate 15 cc. of melted Levinthal agar at 40°C., containing 
1000 units of streptomycin per cc., with 15 to 30 billion organisms in a poured 
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end products of bacterial metabolism; sensitive  organisms  were killed before 
they had a  chance  to reproduce.  AU colonies growing under these circum- 
stances were resistant to 1000 units of streptomycin per cc., and the resistance 
of propagated scions has not changed after a number of subcultures in strep- 
tomycin-free medium. 
Methods  and  Materials 
All strains studied had been preserved within 5 days after isolation from the patient by 
drying and sealing under vacuum of 5 to 10 microns of mercury measured by a  MacLeod 
gauge (19).  The dried culture is seeded in 10 to 20 cc. of Levinthal broth in a 50 to 125 cc. 
flask.  After 20 to 24 hours' incubation at 37.5°C. the broth culture is seeded in 0.5 cc. quanti- 
fies on the surface of a series of Levinthal agar plates and incubated for 6 hours at 37.5°C. 
TABLE II 
Incidence  of Resistant  Survivals  in  Large  Bacterial  Populations  Seeded in  Levinthal  Agar 
Containing  1000  Units of Streptomycin  per  Cc. 
Patient and  Total  Orgsnisms  Colonies 
organisms  cultured  total  Incidence of  Clinical result 
strain  cultured  per plate  survival  resistant colonies* 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
/~l/4ms 
381 
142 
301 
423 
253 
522 
188 
256 
166 
g84 
billions 
25.4 
14.2 
30.1 
29.2 
25.3 
34.8 
18.8 
25.6 
16.6 
28.4 
57 
23 
26 
32 
20 
474 
18 
172 
12 
37 
1:6.7 billion 
1:6.2  " 
1:11.5  " 
1:13.2  " 
1:12.6  " 
1:1.1  " 
1:10.4  " 
1:1.5  " 
1:13.8  " 
1:7.7  " 
Failure 
Recovered 
* Ratio of resistant colonies to total population cultured. 
The growth is then removed by washing each plate with 2 to 4 cc. of plain broth.  The yield 
from the t)lates is combined in one pool; I cc. is added to each of ten to fifteen poured plates, 
together with Levinthal agar containing 1000 units of streptomycin per cc. and the number 
of surviving colonies is recorded after 72 hours' incubation.  The number of organisms per 
cubic centimeter in the pool, determined by making poured plates in Levinthal agar of appro- 
priate dilutions of the heavy suspension,  varied from  15  to 30 billion per cc.  Statistical 
ana2ysis  showed the distribution  of resistant colonies so evenly divided among individual 
plates and groups of five plates that five to ten plates, each seeded with an inoculum between 
15 and 30 billion organisms, provided an adequate index of the ratio of resistant members 
to total population cultured. 
1LESULTS 
The results  are  listed in Table  II.  The  numbers  used  for designating  the 
ten strains  studied by this method  correspond  to those in Table I; as before, 
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patients whose strains became  resistant during treatment.  Again it should 
be emphasized that the tests described were applied in all instances to cultures 
isolated from patients before the start of streptomycin therapy. 
It is seen that all ten cultures studied contain a minute fraction of members 
which before exposure to streptomycin can grow in the presence of I000 units 
per cc. of the antibiotic.  The difference among strains in the number of re- 
sistant members present initially (column  5 of Table II)  is larger than the 
analytical error of the method used; yet the size of  this  fraction seems  to 
bear no relationship to the tendency exhibited by a strain to emerge resistant 
during  treatment of  the  patient.  For  example  the  strain  from patient  I 
yielded one resistant organism  in 6.7 billion when a  total population of 381 
billion was cultured by seeding each of fifteen poured plates containing I000 
units per cc. of Levinthal agar with 25 billion organisms.  Strain 2 had the 
same proportion, whereas strain 3 showed a lower incidence, only one in 11.5 
billion.  It is clear from the figures that two of the strains (Nos.  6 and 8) 
cultivated  from  patients  in  whom  streptomycin was  promptly  successful 
in el~mlnating the infection showed a greater incidence of resistant members 
than those which emerged resistant during treatment. 
Iris important to emphasize that in repeated experiments on the same strain, 
under as controlled conditions as possible, the incidence of resistant members 
varies.  The factors responsible  for this change  are under investigation but 
the results indicate clearly that the size of the bacterial population is  the 
most important single factor among those which determine the potentialities 
of a given strain to develop resistance  during treatment. 
DISCUSSION 
The demonstration of organisms  initially resistant to 1000 units of strep- 
tomycin per cc. in all ten strains of type b H. infl~nzae studied, including 
both those from patients who responded promptly to streptomycin treatment 
as  well  as  some  from more  refractory patients,  adds  convincing  evidence 
to the data obtained from the study of patient 1; resistance  of a strain after 
treatment is not due to action of the antibiotic upon the bacteria but reflects 
a  selective  process  which  by elimination of the  sensitive  members from a 
bacterial population permits the resistant ones  to emerge as sole survivors. 
~u cultures taken from patients prior to treatment, organisms with this degree 
of resistance can be detected with regularity only when very large populations 
are  used.  The  tests  which  measured  the  influences  of  concentrations  of 
stTeptomycin  on relatively small bacterial populations, within the range of 
1 million  to  1700 million  organisms,  demonstrated members resistant to as 
much as 13 units per cc. in only one strain out of the fourteen taken  from 
untreated patients.  On the other hand when the few colonies which occasion- 
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tested for their xc.v..c., significantly higher degrees of resistance  were demon- 
st.rated;  in all instances studied the organisms required between 75 and 1000 
units per  cc.  to prevent growth completely.  It is  clear  that the recovery 
by cultural methods of organisms with this degree of resistance  is a  chance 
phenomenon when an inoculum of this relatively small  magnitude is used. 
It seems  clear  that in all populations of H.  influenzae  there exist initially 
organisms with many different degrees of resistance,  just as has been shown 
by Demerec (17) from a study of the influence of penicillin on staphylococci. 
The number of organisms  exhibiting capacity to grow in 1000 units per cc. 
is so small that enormous bacterial populations have to be examined to demon- 
strate their presence, whereas the number which can thrive in 3 units per cc. 
is  great  enough  to be  readily detected in much smaller  populations.  For 
example, preliminary studies showed that when approximately 50 billion organ- 
isms are seeded into melted Levinthal agar containing only 10 units of strep- 
tomycin per cc., fourteen colonies appeared with 72 hours' incubation.  Nine 
of these, when tested after one subculture in streptomycin-free  medium, showed 
resistance to 1000 units per cc.; growth of four of the others was completely 
prevented by 100 units per cc. and one by 50 units per cc.  When the same 
inoculum was seeded into Levinthal agar containing 1000 units per cc., seven 
colonies grew within 72 hours.  All of these grew as well as the controls in 
1000 units per  cc. 
It was not possible with either of the two methods used to correlate emergence 
of resistance  during treatment with differences between strains from patients 
successfully  treated with streptomycin and  those in whom it failed.  This 
is not surprising  in the test using the smaller  inocula,  for chance  is against 
demonstration of organisms  resistant to  1000 units per cc.  However,  even 
when bacterial populations were large enough to permit their demonstration 
regularly the ratio of resistant organisms  to total population was no greater 
in those strains which emerged  resistant during treatment of patients than 
in those from patients treated successfully with streptomycin.  In fact the 
highest incidence of colonies resistant to 1000 units per cc. occurred in strains 
isolated  from  the  group  in  whom  streptomycin promptly  eliminated  the 
infection. 
All  the data obtained from these procedures  indicate that emergence  of 
resistance of a  strain during treatment of a patient is conditioned not by a 
change in the sensitivity of the organisms as the result of streptomycin action 
nor by an unusually high initial incidence of organisms with resistant traits, 
but rather by the size of the bacterial population, which is presumably closely 
correlated with severity of infection. 
CONCLUSIONS 
1.  Of fourteen patients with type b  H. infl~n~.ae  infections  treated with 
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cases failure was proved to be due to emergence of resistance of the organisms 
to streptomycin. 
2.  The rapid development of resistance to 1000 units of streptomycin per cc. 
during  treatment  argues  against  metabolic adaptation  of the  bacteria. 
3.  Cardul  study  of large  samples  of  initial  bacterial  populations  shows 
resistant  members in  all  ten strains  examined.  The  incidence varies from 
1  in  1.1  billion  to  1  in  13.8  billion  organisms. 
4.  The proportion of resistant members is not significantly higher,  before 
treatment,  in patients who do poorly than  in those who respond promptly. 
5.  The results indicate that emergence of resistance is the result of a selective 
process; after elimination  of sensitive members the very few resistant  ones, 
apparently present in all strains,  make up most or all of the population  in 
the cultures taken after commencement of treatment. 
6.  The  survival  of organisms  which  can  grow  in  high  concentrations of 
streptomycin, either in patients or in vitro, is influenced  more by the size  of 
the bacterial population  than  by any other known factor. 
7.  Since  the bacterial population is relatively small in those patients with 
mild or moderately severe infections the likelihood of a  significant  number 
of  very  resistant  members  being  present  is  remote. 
8.  The  traits  responsible for  resistance  of  the  organisms  are  apparently 
inherited:  (a)  The resistant state of one strain has been transmitted in vitro 
without change in degree through over one hundred subcultures in the absence 
of streptomycin.  (b)  Persistence of resistant organisms in the nasopharynx 
of one patient  during  a  one year period raises  an  important  public health 
problem. 
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